What’s happening at Innocore?

InnoCore Pharmaceuticals today initiated a new formulation development program focused on a specific small molecule drug substance, reinforcing its long-standing commitment to supporting its customers across a range of molecules.

InnoCore attended and presented at the PODD: Partnership Opportunities in Drug Delivery Conference, taking place between 27–28 October 2025 in Boston, MA.

InnoCore Pharmaceuticals today announced a project extension with an existing European biotech partner focused on developing a long-acting injectable protein formulation using its proprietary SynBiosys® technology.

Innocore today announced a new formulation development contract with a returning Top 10 global pharmaceutical company. The new agreement builds on the success of earlier collaborations and further strengthens the long-standing relationship between the two companies.

Meet us at the BioEurope in Vienna from 3 - 5 November! Let’s build the future of Biologics and Peptides together.

Meet us at the CPHI to explore how our SynBiosys® platform is transforming the development of biodegradable long-acting injectables for peptides, proteins, and other biologics.

Join Rob Steendam, at his talk on “SynBiosys®: Long-Acting Injectable Microspheres and In Situ Forming Depots for Delivery of Peptides and Proteins”!

Join InnoCore at BioJapan! Let's partner to shape the future of peptides and biologics together.

InnoCore launches its new website